Eosinophilic Granulomatosis with Polyangiitis (EGPA)

If you are interested in any of our research studies, please contact our research group at 215-614-4417 or email us at rheumatologyresearch@uphs.upenn.edu.

Study Name

Medication Involved

Disease Studied

Currently Enrolling

Benralizumab in eosinophilic granulomatosis with polyangiitis (EGPA) (MANDARA) YES EGPA YES
Nasal Microbiome in ANCA Associated Vasculitis and Relapsing Polychondritis (NMB) NO GPA, MPA, EGPA, & RP YES (EGPA & RP)
5506: The EGPA Registry NO EGPA YES
Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis (LoDoNaVasc) YES GPA, MPA, EGPA, GCA, Takayasu arteritis, PAN YES
One-Time DNA Study for Vasculitis (OTD) NO GPA, MPA, EGPA, GCA, Takayasu arteritis, PAN YES
Clinical Transcriptomics in Systemic Vasculitis (CUTIS) NO GPA, MPA, EGPA, PAN, IgAV, cryoglobulinemic, drug-induced, isolated cutaneous small vessel vasculitis, urticarial YES
Tissue Repository Collection Protocol NO GPA, MPA, EGPA, GCA, Takayasu's arteritis, PAN, cutaneous vasculitis YES